Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

JBM (Healthcare) stock

2161.HK
KYG1090B1077

Price

1.27
Today +/-
-0.00
Today %
-1.56 %
P

JBM (Healthcare) stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the JBM (Healthcare) stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the JBM (Healthcare) stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the JBM (Healthcare) stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze JBM (Healthcare)'s market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

JBM (Healthcare) Stock Price History

DateJBM (Healthcare) Price
11/13/20241.27 undefined
11/12/20241.29 undefined
11/11/20241.28 undefined
11/8/20241.29 undefined
11/7/20241.34 undefined
11/6/20241.31 undefined
11/5/20241.19 undefined
11/4/20241.16 undefined
11/1/20241.17 undefined
10/31/20240.96 undefined
10/30/20240.98 undefined
10/29/20240.97 undefined
10/28/20240.99 undefined
10/25/20241.00 undefined
10/24/20240.95 undefined
10/23/20240.95 undefined
10/22/20240.95 undefined
10/21/20240.96 undefined
10/18/20240.98 undefined
10/17/20240.97 undefined
10/16/20240.98 undefined

JBM (Healthcare) Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into JBM (Healthcare), a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by JBM (Healthcare) from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects JBM (Healthcare)’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of JBM (Healthcare). Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into JBM (Healthcare)’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing JBM (Healthcare)’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on JBM (Healthcare)’s growth potential.

JBM (Healthcare) Revenue, EBIT and net profit per share

DateJBM (Healthcare) RevenueJBM (Healthcare) EBITJBM (Healthcare) Net Income
2024648.42 M undefined162.24 M undefined130.46 M undefined
2023520.32 M undefined70.48 M undefined57.09 M undefined
2022406.14 M undefined38.81 M undefined24.62 M undefined
2021397.16 M undefined73.37 M undefined22.6 M undefined
2020381.54 M undefined53.24 M undefined41.02 M undefined
2019307.52 M undefined64.31 M undefined52.46 M undefined
2018264.33 M undefined52.39 M undefined42.38 M undefined

JBM (Healthcare) Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2018201920202021202220232024
264307381397406520648
-16.2924.104.202.2728.0824.62
55.3055.0549.8749.8739.6639.4252.16
146169190198161205338
425241222457130
-23.81-21.15-46.349.09137.50128.07
-------
-------
893.69893.69893.69813.98893.69891.36883.7
-------
Details

Keystats

ⓘ

Revenue and Growth

The JBM (Healthcare) Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the JBM (Healthcare) is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
2018201920202021202220232024
             
56.8650.9672.7994.3869.84152.27140.81
37.9464.0872.12133.81128.14110.66106.11
188.12207.2242.21.429.482.382.63
31.3630.0563.7848.0247.8754.5691.59
8.4910.8419.236.699.411.2226.41
322.76363.15270.12284.31264.74331.08367.54
201.14187.71179.67190.07181.11165.16152.9
0142.1956.546.2644.9833.8313.88
0000000
394.81387.43593.48591.21568.3591.07571.97
204.35204.35260.54260.54260.54266.84266.84
2.677.827.948.812.8315.115.55
0.80.931.11.11.071.071.02
1.131.291.371.381.331.41.39
             
0.050.080.018.948.949.088.31
6.486.48537.21703.54703.54722.54634.28
90.8141.46121.02202.67227.29280.17358.53
-168-380-917277151-5,518-3,684
000-10.72-10.72-20.76-26.76
97.17147.64657.33904.71929.2985.51970.68
7.2714.527.4413.0122.329.9922.17
2.652.84.635.694.8120.877.03
0.8910.080.050.030.040.11
12.884.7300000
6.967.549.0372.8875.89102.8282.51
0.921.030.10.140.130.190.22
11.667.89446.52195.04137.277.2750.9
76.2174.88107.16102.0797.48100.1694.28
0000000
87.8882.77553.67297.11234.69177.43145.18
11.110.650.430.360.370.37
1.11.261.311.341.291.361.34
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of JBM (Healthcare) provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand JBM (Healthcare)'s financial health and stability.

Assets

JBM (Healthcare)'s assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that JBM (Healthcare) must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of JBM (Healthcare) after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into JBM (Healthcare)'s financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
201820192020202120222023
516953413076
292935434743
000000
0-39-43-35-2923
0-3-78101
110268
11717111611
8256385859145
-10-9-4-22-7-8
-60-5543-24-7-6
-49-4647-101
000000
-20-16-15-151-69-37
0001500-5
-15-6-59-13-76-56
59-44-13-7-8
00000-4
6-52121-2482
71.7447.7833.7635.852.94137.48
000000

JBM (Healthcare) stock margins

The JBM (Healthcare) margin analysis displays the gross margin, EBIT margin, as well as the profit margin of JBM (Healthcare). The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for JBM (Healthcare).

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the JBM (Healthcare)'s sales revenue. A higher gross margin percentage indicates that the JBM (Healthcare) retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the JBM (Healthcare)'s earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the JBM (Healthcare)'s total revenue generated. When comparing the revenue margin year over year, investors can gauge the JBM (Healthcare)'s growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the JBM (Healthcare). Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the JBM (Healthcare)'s financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

JBM (Healthcare) Margin History

JBM (Healthcare) Gross marginJBM (Healthcare) Profit marginJBM (Healthcare) EBIT marginJBM (Healthcare) Profit margin
202452.14 %25.02 %20.12 %
202339.5 %13.54 %10.97 %
202239.77 %9.55 %6.06 %
202149.96 %18.47 %5.69 %
202049.84 %13.95 %10.75 %
201955.18 %20.91 %17.06 %
201855.31 %19.82 %16.03 %

JBM (Healthcare) Stock Sales Revenue, EBIT, Earnings per Share

The JBM (Healthcare) earnings per share therefore indicates how much revenue JBM (Healthcare) has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue JBM (Healthcare) earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates JBM (Healthcare)'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of JBM (Healthcare)’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating JBM (Healthcare)'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

JBM (Healthcare) Revenue, EBIT and net profit per share

DateJBM (Healthcare) Sales per ShareJBM (Healthcare) EBIT per shareJBM (Healthcare) Earnings per Share
20240.73 undefined0.18 undefined0.15 undefined
20230.58 undefined0.08 undefined0.06 undefined
20220.45 undefined0.04 undefined0.03 undefined
20210.49 undefined0.09 undefined0.03 undefined
20200.43 undefined0.06 undefined0.05 undefined
20190.34 undefined0.07 undefined0.06 undefined
20180.3 undefined0.06 undefined0.05 undefined

JBM (Healthcare) business model

JBM (Healthcare) is one of the most popular companies on Eulerpool.com.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

JBM (Healthcare) Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

JBM (Healthcare) historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

JBM (Healthcare) shares outstanding

The number of shares was JBM (Healthcare) in 2023 — This indicates how many shares 891.359 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue JBM (Healthcare) earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates JBM (Healthcare)'s earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of JBM (Healthcare)’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating JBM (Healthcare)'s prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

JBM (Healthcare) dividend history and estimates

In 2023, JBM (Healthcare) paid a dividend amounting to 0.06 HKD. Dividend means that JBM (Healthcare) distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for JBM (Healthcare) provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify JBM (Healthcare)’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating JBM (Healthcare)'s overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

JBM (Healthcare) Dividend History

DateJBM (Healthcare) Dividend
20240.04 undefined
20230.06 undefined
20220.01 undefined

JBM (Healthcare) dividend payout ratio

In 2023, JBM (Healthcare) had a payout ratio of 18.15%. The payout ratio indicates the percentage of the company's profits that JBM (Healthcare) distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for JBM (Healthcare) represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for JBM (Healthcare) could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate JBM (Healthcare)'s payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

JBM (Healthcare) Payout Ratio History

DateJBM (Healthcare) Payout ratio
202418.15 %
202318.15 %
202218.15 %
202118.15 %
202018.15 %
201918.15 %
201818.15 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for JBM (Healthcare).

JBM (Healthcare) shareholders

%
Name
Stocks
Change
Date
62.16138 % Sum (Kwong Yip Derek)507,423,34609/9/2024
9.29805 % Yunnan Baiyao Group Co., Ltd.75,900,00003/31/2024
5.10548 % Tycoon Group Holdings Ltd41,676,000-13,324,0007/29/2024
1.59211 % Yim (Chun Leung)12,996,39009/9/2024
0.07606 % Wong (Yat Wai)620,86209/9/2024
0.04649 % Yeung (Kwok Chun)379,50009/9/2024
0.00641 % Bessemer Trust Company, N.A. (US)52,35407/31/2024
0.00465 % Chan (Kam Chiu)37,95009/9/2024
0.00012 % Dimensional Fund Advisors, L.P.1,01807/31/2024
0.00012 % American Century Investment Management, Inc.1,00006/30/2024
1
2

JBM (Healthcare) Executives and Management Board

Mr. Yat Wai Wong(59)
JBM (Healthcare) Chief Executive Officer, Executive Director (since 2020)
Compensation 2.24 M
Mr. Kwok Chun Yeung(63)
JBM (Healthcare) Non-Executive Director
Compensation 180,000
Mr. Kam Chiu Chan(73)
JBM (Healthcare) Independent Non-Executive Director
Compensation 180,000
Mr. Shut Lee Lau(53)
JBM (Healthcare) Independent Non-Executive Director
Compensation 180,000
Mr. Ting Lung Luk(60)
JBM (Healthcare) Independent Non-Executive Director
Compensation 180,000
1
2
3

JBM (Healthcare) Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Television Broadcasts Stock
Television Broadcasts
SupplierCustomer0,300,820,410,590,89
Jacobson Pharma Stock
Jacobson Pharma
SupplierCustomer-0,260,760,880,820,46
Alibaba Group Holding Stock
Alibaba Group Holding
SupplierCustomer-0,320,370,69-0,030,78
EXACT Sciences Stock
EXACT Sciences
SupplierCustomer-0,450,560,630,200,84
Hong Kong Technology Venture Stock
Hong Kong Technology Venture
SupplierCustomer-0,490,880,810,330,49
1

Most common questions regarding JBM (Healthcare)

What is the P/E ratio of JBM (Healthcare) 2024?

The JBM (Healthcare) P/E ratio is 8.6.

What is the P/S ratio of JBM (Healthcare) 2024?

The JBM (Healthcare) P/S ratio is 1.73.

What is the Quality Investing of JBM (Healthcare)?

The Quality Investing for JBM (Healthcare) is 3/10.

What is the revenue of JBM (Healthcare) 2024?

The JBM (Healthcare) revenue is 648.42 M HKD.

How high is the profit of JBM (Healthcare) 2024?

The JBM (Healthcare) profit is 130.46 M HKD.

What is the business model of JBM (Healthcare)

No history available for JBM (Healthcare).

What is the JBM (Healthcare) dividend?

JBM (Healthcare) pays a dividend of 0.01 HKD distributed over payouts per year.

How often does JBM (Healthcare) pay dividends?

The dividend cannot currently be calculated for JBM (Healthcare) or the company does not pay out a dividend.

What is the JBM (Healthcare) ISIN?

The ISIN of JBM (Healthcare) is KYG1090B1077.

What is the JBM (Healthcare) ticker?

The ticker of JBM (Healthcare) is 2161.HK.

How much dividend does JBM (Healthcare) pay?

Over the past 12 months, JBM (Healthcare) paid a dividend of 0.04 HKD . This corresponds to a dividend yield of about 3.19 %. For the coming 12 months, JBM (Healthcare) is expected to pay a dividend of 0.04 HKD.

What is the dividend yield of JBM (Healthcare)?

The current dividend yield of JBM (Healthcare) is 3.19 %.

When does JBM (Healthcare) pay dividends?

JBM (Healthcare) pays a quarterly dividend. This is distributed in the months of January, September, January, September.

How secure is the dividend of JBM (Healthcare)?

JBM (Healthcare) paid dividends every year for the past 3 years.

What is the dividend of JBM (Healthcare)?

For the upcoming 12 months, dividends amounting to 0.04 HKD are expected. This corresponds to a dividend yield of 3.19 %.

In which sector is JBM (Healthcare) located?

JBM (Healthcare) is assigned to the 'Health' sector.

Wann musste ich die Aktien von JBM (Healthcare) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of JBM (Healthcare) from 9/17/2024 amounting to 0.041 HKD, you needed to have the stock in your portfolio before the ex-date on 8/15/2024.

When did JBM (Healthcare) pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of JBM (Healthcare) in the year 2023?

In the year 2023, JBM (Healthcare) distributed 0.06 HKD as dividends.

In which currency does JBM (Healthcare) pay out the dividend?

The dividends of JBM (Healthcare) are distributed in HKD.

All fundamentals about JBM (Healthcare)

Our stock analysis for JBM (Healthcare) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JBM (Healthcare) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.